BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20637249)

  • 21. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.
    Scahill L; McCracken J; McDougle CJ; Aman M; Arnold LE; Tierney E; Cronin P; Davies M; Ghuman J; Gonzalez N; Koenig K; Lindsay R; Martin A; McGough J; Posey DJ; Swiezy N; Volkmar F; Ritz L; Vitiello B
    J Child Adolesc Psychopharmacol; 2001; 11(4):377-88. PubMed ID: 11838820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone monotherapy in preschool children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; De Vito G
    J Child Neurol; 2001 Jun; 16(6):395-400. PubMed ID: 11417603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
    Zuddas A; Di Martino A; Muglia P; Cianchetti C
    J Child Adolesc Psychopharmacol; 2000; 10(2):79-90. PubMed ID: 10933118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Belsito KM; Law PA; Kirk KS; Landa RJ; Zimmerman AW
    J Autism Dev Disord; 2001 Apr; 31(2):175-81. PubMed ID: 11450816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review.
    DelBello MP; Kowatch RA; Warner J; Schwiers ML; Rappaport KB; Daniels JP; Foster KD; Strakowski SM
    J Child Adolesc Psychopharmacol; 2002; 12(4):323-30. PubMed ID: 12625992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.
    Chez MG; Buchanan CP; Aimonovitch MC; Becker M; Schaefer K; Black C; Komen J
    J Child Neurol; 2002 Nov; 17(11):833-7. PubMed ID: 12585724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An open trial of risperidone in autistic children].
    Nishimura M; Hashimoto T; Miyazaki M; Mori K; Kuroda Y
    No To Hattatsu; 2003 Nov; 35(6):473-7. PubMed ID: 14631742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
    Scahill L; Hallett V; Aman MG; McDougle CJ; Eugene Arnold L; McCracken JT; Tierney E; Deng Y; Dziura J; Vitiello B;
    J Autism Dev Disord; 2013 Mar; 43(3):739-46. PubMed ID: 23104617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive effects of risperidone in children with autism and irritable behavior.
    Aman MG; Hollway JA; McDougle CJ; Scahill L; Tierney E; McCracken JT; Arnold LE; Vitiello B; Ritz L; Gavaletz A; Cronin P; Swiezy N; Wheeler C; Koenig K; Ghuman JK; Posey DJ
    J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):227-36. PubMed ID: 18582177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.
    Remington G; Sloman L; Konstantareas M; Parker K; Gow R
    J Clin Psychopharmacol; 2001 Aug; 21(4):440-4. PubMed ID: 11476129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania.
    Pavuluri MN; Janicak PG; Carbray J
    J Child Adolesc Psychopharmacol; 2002; 12(3):271-3. PubMed ID: 12427302
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.
    Arnold LE; Aman MG; Martin A; Collier-Crespin A; Vitiello B; Tierney E; Asarnow R; Bell-Bradshaw F; Freeman BJ; Gates-Ulanet P; Klin A; McCracken JT; McDougle CJ; McGough JJ; Posey DJ; Scahill L; Swiezy NB; Ritz L; Volkmar F
    J Autism Dev Disord; 2000 Apr; 30(2):99-111. PubMed ID: 10832774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.
    Monnelly EP; Ciraulo DA; Knapp C; Keane T
    J Clin Psychopharmacol; 2003 Apr; 23(2):193-6. PubMed ID: 12640221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of functional analysis methodology in the evaluation of medication effects.
    Crosland KA; Zarcone JR; Lindauer SE; Valdovinos MG; Zarcone TJ; Hellings JA; Schroeder SR
    J Autism Dev Disord; 2003 Jun; 33(3):271-9. PubMed ID: 12908830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of aggressive behavior in dementia with the anticonvulsant topiramate: a retrospective pilot study.
    Fhager B; Meiri IM; Sjögren M; Edman A
    Int Psychogeriatr; 2003 Sep; 15(3):307-9. PubMed ID: 14756165
    [No Abstract]   [Full Text] [Related]  

  • 37. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
    Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
    J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of risperidone in a paediatric population: an observational study.
    King B; Zwi K; Nunn K; Longworth J; Dossetor D
    J Paediatr Child Health; 2003; 39(7):523-7. PubMed ID: 12969207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.
    Levy SE; Souders MC; Wray J; Jawad AF; Gallagher PR; Coplan J; Belchic JK; Gerdes M; Mitchell R; Mulberg AE
    Arch Dis Child; 2003 Aug; 88(8):731-6. PubMed ID: 12876177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.
    Vo LC; Snyder C; McCracken C; McDougle CJ; McCracken JT; Aman MG; Tierney E; Arnold LE; Levi D; Kelleman M; Carroll D; Morrissey J; Vitiello B; Scahill L
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):900-908. PubMed ID: 27726426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.